Journal of the American Academy of Dermatology
Volume 62, Issue 2 , Pages 239-246 , February 2010

Efficacy of imipenem therapy for Nocardia actinomycetomas refractory to sulfonamides

  • Mahreen Ameen, MPH, MRCP, MD

      Affiliations

    • St John's Institute of Dermatology, Guy's and St Thomas' Trust, London, United Kingdom
    • Corresponding Author InformationReprint requests: Mahreen Ameen, MPH, MRCP, MD, St John's Institute of Dermatology, Guy's and St Thomas' Hospital, Westminster Bridge Road, London SE1 7EH.
    • ,
  • Roberto Arenas, MD

      Affiliations

    • Department of Mycology, Hospital General Dr Manuel Gea Gonzalez, Mexico City, Mexico
    • ,
  • Elsa Vásquez del Mercado, MD

      Affiliations

    • Department of Mycology, Hospital General Dr Manuel Gea Gonzalez, Mexico City, Mexico
    • ,
  • Ramón Fernández, MD

      Affiliations

    • Department of Mycology, Hospital General Dr Manuel Gea Gonzalez, Mexico City, Mexico
    • ,
  • Edoardo Torres, MD

      Affiliations

    • Department of Dermatology, Hospital General Dr Manuel Gea Gonzalez, Mexico City, Mexico
    • ,
  • Rogelio Zacarias, MD

      Affiliations

    • Department of Internal Medicine, Hospital General Dr Manuel Gea Gonzalez, Mexico City, Mexico

,Accepted 10 June 2009.

References 

  1. Mariat F, Destombes P, Segretain G. The mycetomas: clinical features, pathology, etiology and epidemiology. Contrib Microbiol Immunol. 1977;4:1–39
  2. Lopez-Martinez R, Mendez-Tovar JL, Lavalle P, Welsh O, Saúl A, Macotela Ruíz E. Epidemiology of mycetoma in Mexico: study of 2,105 cases. Gac Med Mex. 1992;128:477–481
  3. Buot G, Lavalle P, Mariat F, Suchil P. Étude épidémiologique des mycetomas au Mexique. A propos de 502 cas. Bull Soc Pathol Exot Filiales. 1987;80:329–339
  4. Welsh O, Lopez R. Micetomas con diseminacion pulmonar. Med Cutan Ibero Lat Am. 1985;13:517–523
  5. Fahal AH. Mycetoma: a thorn in the flesh. Trans R Soc Trop Med Hyg. 2004;98:3–11
  6. Mahgoub ES. Treatment of actinomycetoma with sulphamethoxazole plus trimethoprim. Am J Trop Med Hyg. 1972;21:332–335
  7. Dieng MT, Niang SO, Diop B, Ndiaye B. Actinomycetomas in Senegal: study of 90 cases. Bull Soc Pathol Exot. 2005;98:18–20
  8. Mahgoub ES. Medical management of mycetoma. Bull World Health Organ. 1976;54:3003–3311
  9. Welsh O, Sauceda E, Gonzalez J, Ocampo J. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J Am Acad Dermatol. 1987;17:443–448
  10. Bonifaz A, Flores P, Saul A, Carrasco-Gerard E, Ponce RM. Treatment of actinomycetoma due to Nocardia spp. with amoxicillin-clavulanate. Br J Dermatol. 2007;156:308–311
  11. Damle DK, Mahajan PM, Pradhan SN, Belgaumkar VA, Gosavi AP, Tolat SN, et al. Modified Welsh regimen: a promising therapy for actinomycetoma. J Drugs Dermatol. 2008;7:853–856
  12. Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol. 2005;53:931–951
  13. Arenas R. Micología Médica Ilustrada. 3a ed. México: Interamericana-McGraw-Hill; 2008;p.127-48
  14. Wallace RJ, Septimus EJ, Musher DM, Martin RR. Disk diffusion susceptibility testing of Nocardia species. J Infect Dis. 1977;135:568–576
  15. Gombert ME, Aulicino TM. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Antimicrob Agents Chemother. 1983;24:810–811
  16. Welsh O. Mycetoma: current concepts in treatment. Int J Dermatol. 1991;30:387–398
  17. Gomez-Flores A, Welsh O, Said-Fernández S, Lozano-Garza G, Tavarez-Alejandro RE, Vera-Cabrera L. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother. 2004;48:832–837
  18. Khardori N, Shawar R, Gupta R, Rosenbaum B, Rolston K. In vitro antimicrobial susceptibilities of Nocardia species. Antimicrob Agents Chemother. 1993;37:882–884
  19. McNeil MM, Brown JM, Jarvis WR, Ajello L. Comparison of species distribution and antimicrobial susceptibility of aerobic actinomycetes from clinical specimens. Rev Infect Dis. 1990;12:778–783
  20. Ogg G, Lynn WA, Peters M, Curati W, McLaughlin JE, Shaunak S. Cerebral Nocardia abscesses in a patient with AIDS: correlation of magnetic resonance and white cell scanning images with neuropathological findings. J Infect. 1997;35:311–313
  21. Narushima M, Susuki H, Kasai T, Tsuzura Y, Tomita S, Endoh S, et al. Pulmonary nocardiosis in a patient treated with corticosteroid therapy. Respirology. 2002;7:87–89
  22. Hui CH, Au VW, Rowland K, Slavotinek JP, Gordon DL. Pulmonary nocardiosis revisited: experience of 35 patients at diagnosis. Respir Med. 2003;97:709–717
  23. Yoneyama T, Yamakani I, Mine S. Nocardial brain abscess: surgery and postoperative antibiotic therapy. No Shinkei Geka. 2004;32:457–462
  24. Folgaresi M, Ferdani G, Coppini M, Pincelli C. Primary cutaneous nocardiosis. Eur J Dermatol. 1998;8:430–431
  25. Baril L, Boiron P, Manceron V, Ely SO, Jamet P, Favre E, et al. Refractory craniofacial actinomycetoma due to Streptomyces somaliensis that required salvage therapy with amikacin and imipenem. Clin Infect Dis. 1999;29:460–461
  26. Kashima M, Kano R, Mikami Y, Takahama H, Ito M, Hasegawa A, et al. A successfully treated case of mycetoma due to Nocardia veterana. Br J Dermatol. 2005;152:1349–1352
  27. Poncio Mendes R, Negroni R, Bonifaz A, Pappagianis D. New aspects of some endemic mycoses. Med Mycol. 2000;38(Suppl):237–241
  28. Adamis G, Papaioannou MG, Giamarellos-Bourboulis EJ, Gargalianos P, Kosmidis J, Giamarellou H. Pharmacokinetic interactions of ceftazidime, imipenem and aztreonam with amikacin in healthy volunteers. Int J Antimicrob Agents. 2004;23:144–149
  29. Chaudhuri BN, Maiti PK, Sil J. Antibiotic sensitivity patterns of actinomycetes isolated from patients with actinomycetomas. Indian J Med Res. 1997;105:162–166
  30. Bonifaz A, Gonzalez-Silva A, Albrandt-Salmeron A, Padilla Mdel C, Saúl A, Ponce RM. Utility of helical computed tomography to evaluate the invasion of actinomycetoma: a report of 21 cases. Br J Dermatol. 2008;158:698–704
  31. Livermore DM, Sefton AM, Scott GM. Properties and potential of ertapenem. J Antimicrob Chemother. 2003;52:331–344

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)00774-9

doi: 10.1016/j.jaad.2009.06.043

Journal of the American Academy of Dermatology
Volume 62, Issue 2 , Pages 239-246 , February 2010

Article Tools

* Image Usage & Resolution